UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to ________ Commission File Number: 001-39563 GEOVAX LABS, INC. (Exact name of registrant as specified in its charter) Delaware 87-0455038 (State or other jurisdi ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the fiscal year ended December 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File No. 001-39563 GEOVAX LABS, INC. (Exact name of registrant as specified in its charter) Delaware 87-0455038 (State or other jurisdiction of (IRS Employer incorporation or organization) Identif ...

GeoVax Labs, Inc. (NASDAQ:GOVX) Q3 2022 Earnings Conference Call November 9, 2022 4:30 PM ET Company Participants Gabrielle DeGravina - CG Capital David Dodd - Chairman, President and Chief Executive Officer Mark Reynolds - Chief Financial Officer Mark Newman - Chief Scientific Officer John Sharkey - Head, Business Development Kelly McKee - Chief Medical Officer Conference Call Participants Jeffrey Kraws - Crystal Research Associates Robert LeBoyer - Noble Capital Operator Good afternoon and welcome everyon ...

GeoVax Labs, Inc. (NASDAQ:GOVX) Q2 2022 Earnings Conference Call August 1, 2022 4:30 PM ET Company Participants David Dodd – Chairman and Chief Executive Officer Mark Reynolds – Chief Financial Officer Mark Newman – Chief Scientific Officer John Sharkey – Head, Business Development Conference Call Participants Jason McCarthy - Maxim Group Jeff Kraws - Crystal Research Kumarguru Raja - Brookline Capital Markets Operator Good afternoon and welcome everyone to the GeoVax Second Quarter 2022 Corporate Update Ca ...

GeoVax Labs, Inc. (NASDAQ:GOVX) Q4 2021 Earnings Conference Call March 9, 2022 4:30 PM ET Company Participants Jules Abraham - CORE, Investor Relations David Dodd - Chairman and Chief Executive Officer Mark Reynolds - Chief Financial Officer Mark Newman - Chief Scientific Officer John Sharkey - Head, Business Development Conference Call Participants Jason McCarthy - Maxim Group Operator Good afternoon. And welcome everyone to the GeoVax Fourth Quarter Year End 2021 Corporate Update Call. I am Chuck with Cho ...

GeoVax Labs, Inc. (NASDAQ:GOVX) Q3 2021 Earnings Conference Call November 11, 2021 4:30 PM ET Company Participants Jules Abraham - Investor Relations David Dodd - Chairman and Chief Executive Officer Mark Newman - Chief Scientific Officer Mark Reynolds - Chief Financial Officer John Sharkey - Head, Business Development Don Diamond - Professor, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope Conference Call Participants Jason McCarthy - Maxim Group Operator Good afternoon and we ...

GeoVax Labs, Inc. (NASDAQ:GOVX) Q2 2021 Earnings Conference Call August 11, 2021 4:30 PM ET Company Participants Jules Abraham - CORE, Investor Relations David Dodd - Chairman and Chief Executive Officer Mark Newman - Chief Scientific Officer Mark Reynolds - Chief Financial Officer Conference Call Participants Jason McCarthy - Maxim Group Jeffrey Kraws - Crystal Research Operator Good day and welcome to the GeoVax Second Quarter 2021 Corporate Update Call. I am [Gran], with Chorus Call and will facilitate ...

GeoVax Labs, Inc. (NASDAQ:GOVX) Q1 2021 Earnings Conference Call May 6, 2021 4:30 PM ET Company Participants Jules Abraham - Director of Public Relations, CORE IR David Dodd - Chairman & Chief Executive Officer Mark Newman - Chief Scientific Officer Mark Reynolds - Chief Financial Officer Conference Call Participants Jason McCarthy - Maxim Group Kumar Raja - Brookline Capital Markets Jeffrey Kraws - Crystal Research Operator Good afternoon, and welcome everyone to the GeoVax First Quarter 2021 Conference Ca ...

GeoVax Labs, Inc. (NASDAQ:GOVX) Q4 2020 Earnings Conference Call March 24, 2021 8:00 AM ET Company Participants Scott Gordon - MD, CORE IR David Dodd - Chairman & CEO Mark Reynolds - CFO Mark Newman - Chief Scientific Officer Conference Call Participants Jason McCarthy - Maxim Group Operator Good morning and welcome everyone to the GeoVax Fourth Quarter Year-end 2020 Corporate Update Call. I am Jayson with Chorus Call and will facilitate today's call. With me are David Dodd, Chairman and CEO; Mark Reynolds, ...

Call Start: 08:15 January 1, 0000 8:59 AM ET GeoVax Labs, Inc. (NASDAQ:GOVX) Q3 2020 Earnings Conference Call November 6, 2020, 08:15 AM ET Company Participants Scott Gordon - MD, CORE IR David Dodd - Chairman & CEO Mark Reynolds - CFO Mark Newman - CSO Conference Call Participants Jason McCarthy - Maxim Group Jeffrey Kraws - Crystal Research Associates Operator Good morning and welcome to the GeoVax Third Quarter 2020 Corporate Update Call. I am Cole with Chorus Call and will facilitate today's call. With ...